1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : BIOTECH
  4. PROTAGONIST THERAPEUTICS INC
Protagonist Therapeutics Inc XNAS: PTGX

Protagonist Therapeutics Inc Live Share Price Today, Share Analysis and Chart

Turnaround Potential
about

Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline p...

Read More
53.00 0.18 (0.34%)
63.08% Gain from 52W Low
752.7K
XNAS Volume

XNAS 11 Jul, 2025 5:30 PM (EDT)

Watchlist

Portfolio

Alert

Share
Durability score
Medium Financial Strength
38.9 / 100
Valuation Score
Mid Valuation
31.5 / 100
Momentum Score
Technically Moderately Bullish
60.0 / 100
Turnaround Potential These stocks may be affordable or expensive due to their medium quality and a good technical scoring. However, their reasonable financials successfully attract investors. View Similar Embed DVM
Analyst Price Target
69
1Yr Price target upside is 30%
11 analysts

17

S

8

W

2

O

1

T

SWOT Analysis

Protagonist Therapeutics Inc Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..